- Supply challenges are currently affecting the availability of drugs due to issues within the pharmaceutical wholesale and supply chain sector.
- FDA regulates drug shortages and systemic supply chain issues in the US.
The FDA and the University of Utah were among the groups that tracked drug shortages that occurred during 2024.
3 reports, 1 independent
Updated Jul 9
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA and the University of Utah were among the groups that tracked drug shortages that occurred during 2024.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
University of Utah
public coeducational space-grant research university in Salt Lake City, Utah, United States
Related events
- The FDA is monitoring drug industry practices and pricing, utilizing studies published by JAMA.
- FDA clearance drives market expansion and coverage for NeurAxis, Inc.
- Future sales of a product are contingent upon obtaining the necessary FDA registration and labeling, while the state simultaneously announces actions to remove regulatory barriers.
- Bill Cassidy and Chris Murphy urged the FDA to assist in stabilizing the healthcare system and address drug shortages.
- Data was presented in Athens supporting a future U.S. NDA submission to the FDA.